The President of the United States has announced that he is removing a series of regulations to speed up tests with antiretroviral, antimalarial and antimalarial drugs to treat those who have become infected with the coronavirus and have symptoms. One of them is hydroxychloroquine, prescribed to treat malaria and rheumatoid arthritis, which according to Donald Trump “can change the rules of the game.”
In U.S.A. there are more than 7,000 infected that have been diagnosed and a hundred people have already died. President Trump has again referred to the coronavirus as “the Chinese virus,” despite protests that expression has sparked in Beijing.
“It has been on the market for a long time, so we know that if it does not have the desired effect, it will not kill anyone,” Trump said of the drug that the US is going to try. at his daily press conference at the White House. The drug will be distributed by prescription by the US Food and Drug Administration. The director of this, Stephen Hahn, expressed optimism at the same press conference at the White House: “I hope for an improvement in this situation.”
The US federal government plans to offer medications already marketed for other ailments to doctors who consider that they can treat coronavirus patients with them, in exchange for obtaining data on the evolution of those infected, to better understand the nature of the disease. “If there is an experimental medication that is possibly available, a doctor might request that that medication be used in a patient. We have criteria for rapid approval, “said Director Hahn.
The president has explained that he eliminates the cumbersome medical regulations to test in coronavirus patients a series of medicines that have already been marketed under names like Plaquenil, Axemal, Dolquine, Ilinol, or Quensyl. “We have to remove every unnecessary barrier to achieve the rapid deployment of safe and effective treatments and we believe we will have some good answers,” said Trump.
45 American patients from Seattle are already participating in the first test of a vaccine, all between the ages of 18 and 55 and will receive two doses in a 28-day period. According to the White House, they have been divided into three groups, each with a different dose, in order to measure the effect. For 14 months, patients will have 11 follow-up visits, something for which they charge $ 1,100 each. If there was a vaccine, it would not arrive for at least a year. .